What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Businesses/Biotechnology / Healthcare/Amgen Inc.

AI Visibility & Sentiment

Amgen Inc.

Amgen is a global biopharmaceutical leader dedicated to discovering and manufacturing innovative human therapeutics for serious illnesses. By leveraging advanced human genetics and biotechnology, the company addresses significant medical needs in oncology, cardiovascular disease, and rare conditions.

Active Monitoring

amgen.com

Biotechnology / Healthcare

Partial scan

AI Visibility Score

47/100

Moderate

Sentiment Score

86/100

Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core

adjacent

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Amgen Inc. today.

Amgen commands strong authority in institutional reputation and high-level category trust, effectively securing top-tier positions when users inquire about industry leadership. However, there is a critical disconnect between this corporate brand strength and product-specific visibility, where Amgen often fails to appear during high-intent clinical decision-making queries.

Working in your favor

Securing #1 and #2 positions for category trust and industry reputation queries in AI Overviews.

Effective presence in patient support program discussions, ranking #3 for queries regarding advanced assistance resources.

Resonant branding with the chronically ill patient advocate persona, achieving an average position of 1.0.

Gaps to close

Complete absence in specific therapeutic selection queries, particularly regarding biologics management and injectable LDL cholesterol treatments.

Lack of visibility in clinical-focused queries for oncology support, where competitors consistently outrank Amgen.

Underperformance in biosimilar vs. originator comparison queries, where the brand should hold clear thought leadership.

Opportunities

Capitalize on existing institutional trust to bridge the gap into clinical therapeutic selection content.

Develop dedicated content addressing the mechanics of biosimilar advantages to capture searchers currently not seeing Amgen in comparative research.

Optimize technical medical content to better align with the language used by clinical oncology and pharmacy procurement decision-makers.

Highest-Impact Actions

Develop and deploy clinical-grade, decision-support content specifically mapped to the biologic and LDL cholesterol management queries.

Amgen has brand trust but is losing the 'last mile' of the decision-making process by failing to appear in therapeutic selection searches.

Create authoritative white papers or clinical comparisons on biosimilars versus originator biologics.

These queries represent high-intent research by healthcare professionals and purchasers where Amgen is currently absent, despite its market position.

Optimize oncology support web architecture to explicitly feature Amgen's patient support programs.

Competitors are successfully leveraging support-centric language to dominate patient-focused search results; strengthening this signal will improve visibility with advocates.

Value Proposition

Amgen utilizes a 'Biology First' approach, combining protein engineering expertise with large-scale manufacturing to produce complex biologic medicines with a high-reliability supply chain.

Overview

Mission

To serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.

Products & Services

Enbrel (etanercept)Prolia (denosumab)Repatha (evolocumab)Otezla (apremilast)Blincyto (blinatumomab)

Current State

Visibility Landscape

A high-level view of how Amgen Inc. performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

	ChatGPT	Claude	Gemini	AI Overviews
Reputation1q Brand recognition & direct queries	—	—	—	97
Core3q Product/service category queries	—	—	—	70
Growth Areas5q Adjacent, aspirational & visionary	—	—	—	72

Competitive Landscape

Amgen Inc.7 mentions

Novo Nordisk A/S4 mentions

WuXi Biologics4 mentions

Bimzelx3 mentions

Skyrizi3 mentions

Taltz3 mentions

Tremfya3 mentions

Cosentyx3 mentions

Cancer Support Community3 mentions

Samsung Biologics3 mentions

Reclast3 mentions

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Amgen Inc.'s AI visibility.

Key Findings

Strength

Securing #1 and #2 positions for category trust and industry reputation queries in AI Overviews.

Strength

Effective presence in patient support program discussions, ranking #3 for queries regarding advanced assistance resources.

Strength

Resonant branding with the chronically ill patient advocate persona, achieving an average position of 1.0.

Recommended Actions

Develop and deploy clinical-grade, decision-support content specifically mapped to the biologic and LDL cholesterol management queries.

Amgen has brand trust but is losing the 'last mile' of the decision-making process by failing to appear in therapeutic selection searches.

Create authoritative white papers or clinical comparisons on biosimilars versus originator biologics.

These queries represent high-intent research by healthcare professionals and purchasers where Amgen is currently absent, despite its market position.

Optimize oncology support web architecture to explicitly feature Amgen's patient support programs.

Competitors are successfully leveraging support-centric language to dominate patient-focused search results; strengthening this signal will improve visibility with advocates.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Therapeutic Selection And Condition Management(3 queries)

“what are the most effective biologic options for managing moderate to severe plaque psoriasis besides standard topicals”

0/1 platforms mentioned

Core

AI Overviews

1.Bimzelx

2.Skyrizi

3.Taltz

4.Tremfya

5.Cosentyx

+1 more

“compare leading injectable treatments for lowering LDL cholesterol for patients who cannot tolerate statins”

0/1 platforms mentioned

Core

Clinical Oncology Specialist · Buyer

AI Overviews

1.Evkeeza

“what are the best long-term bone density treatments for postmenopausal osteoporosis that are administered via injection”

1/1 platforms mentioned

Core

Clinical Oncology Specialist · Buyer

AI Overviews

1.Reclast

2.Evenity

3.Forteo

4.Tymlos

5.Boniva

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Psoriasis Treatment in 2025: More Options, Better Outcomes

practicaldermatology.com

Web1 ref

Psoriasis - Diagnosis and treatment - Mayo Clinic

mayoclinic.org

Web1 ref

Which Biologic is Best for Psoriasis Treatment? - EMJ

emjreviews.com

Web1 ref

Biologic Treatment Algorithms for Moderate-to-Severe ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Psoriasis in 2025: Year in Review - HCPLive

hcplive.com

Web1 ref

11 Biologic Medications for Psoriasis Treatment - WebMD

webmd.com

Web1 ref

Tolerability and comparative effectiveness of TNF, IL-17 and IL ...

pubmed.ncbi.nlm.nih.gov

Gov1 ref

TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis

pmc.ncbi.nlm.nih.gov

Gov1 ref

The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing ...

onlinelibrary.wiley.com

Web1 ref

IL-17 vs. IL-23: The Latest Comparison

thedermdigest.com

Web1 ref

Dermatology Times 2025 Year in Review: Psoriasis

dermatologytimes.com

Web1 ref

Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Phase 3 Results Signal a New Era for Oral Targeted Therapy in ...

dermatologytimes.com

Web1 ref

Systemic Pharmacologic Treatments for Plaque Psoriasis | AAFP

aafp.org

Web1 ref

Biologics for Psoriasis - Everything You Need to Know

psoriasis.org

Web1 ref

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned March 16, 2026.

Amgen Inc.

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Start getting
recommended by AI.

Frequently asked questions

Amgen Inc.

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Start gettingrecommended by AI.

Frequently asked questions

Start getting
recommended by AI.